Home BoRui Pharmaceuticals Plunges 20% Amid Controlling Shareholder's Securities Manipulation Allegations and Hong Kong IPO Filing

BoRui Pharmaceuticals Plunges 20% Amid Controlling Shareholder's Securities Manipulation Allegations and Hong Kong IPO Filing

Jun 22, 2026 10:35 CST Updated 10:35
Northland

Innovative Biopharmaceutical Manufacturer

InventisBio

Innovative Drug Developer

Zhongsheng Pharmaceutical

Pharmaceutical R&D and Manufacturer

(Source: Caiwen)

In terms of news,Borui MedicineAnnouncement: The actual controller, Yuan Jiandong, has been released on bail pending trial due to suspected manipulation of the securities market.

On June 22, the innovative drug concept continued to weaken during trading.Borui Medicine (688166.SH)20cm limit down,Northland(920047.BJ)InventisBioZhongsheng Pharmaceutical(002317.SZ)Aidea Pharmaceutical(688488.SH)Baihua Medical(600721.SH)Awaiting a decline in tandem.

In terms of news flow, Borui Medicine announced that its actual controller, Yuan Jiandong, has been released on bail pending trial due to suspected manipulation of the securities market.